TD Ameritrade Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-39
| Closed | -$20K | – | 446 |
|
|
2023
Q2 | $20K | Sell |
39
-10
| -20% | -$5.13K | ﹤0.01% | 283 |
|
|
2023
Q1 | $28K | Sell |
49
-26
| -35% | -$14.9K | ﹤0.01% | 275 |
|
|
2022
Q4 | $41K | Sell |
75
-55
| -42% | -$30.1K | ﹤0.01% | 266 |
|
|
2022
Q3 | $66K | Sell |
130
-71
| -35% | -$36K | ﹤0.01% | 263 |
|
|
2022
Q2 | $109K | Sell |
201
-63
| -24% | -$34.2K | ﹤0.01% | 251 |
|
|
2022
Q1 | $156K | Buy |
264
+37
| +16% | +$21.9K | ﹤0.01% | 254 |
|
|
2021
Q4 | $151K | Buy |
227
+38
| +20% | +$25.3K | ﹤0.01% | 257 |
|
|
2021
Q3 | $83K | Sell |
189
-8
| -4% | -$3.51K | ﹤0.01% | 279 |
|
|
2021
Q2 | $99K | Buy |
197
+27
| +16% | +$13.6K | ﹤0.01% | 282 |
|
|
2021
Q1 | $79K | Hold |
170
| – | – | ﹤0.01% | 293 |
|
|
2020
Q4 | $79K | Sell |
170
-19
| -10% | -$8.83K | ﹤0.01% | 293 |
|
|
2020
Q3 | $83K | Buy |
189
+9
| +5% | +$3.95K | ﹤0.01% | 279 |
|
|
2020
Q2 | $65K | Buy |
180
+5
| +3% | +$1.81K | ﹤0.01% | 286 |
|
|
2020
Q1 | $50K | Sell |
175
-20
| -10% | -$5.71K | ﹤0.01% | 293 |
|
|
2019
Q4 | $63K | Buy |
195
+125
| +179% | +$40.4K | ﹤0.01% | 293 |
|
|
2019
Q3 | $20K | Buy |
70
+44
| +169% | +$12.6K | ﹤0.01% | 379 |
|
|
2019
Q2 | $8K | Buy |
26
+11
| +73% | +$3.39K | ﹤0.01% | 445 |
|
|
2019
Q1 | $4K | Sell |
15
-25
| -63% | -$6.67K | ﹤0.01% | 477 |
|
|
2018
Q4 | $9K | Sell |
40
-1
| -2% | -$225 | ﹤0.01% | 368 |
|
|
2018
Q3 | $10K | Buy |
+41
| New | +$10K | ﹤0.01% | 333 |
|